These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 10800166

  • 1. Coexistence of two distinct cell populations (CD56(+)TcRgammadelta(+) and CD56(+)TcRgammadelta(-)) in a case of aggressive CD56(+) lymphoma/leukemia.
    Camera A, Pezzullo L, Villa MR, Luciano L, Pane F, Izzo B, Boccuni P, Di Noto R, Del Vecchio L, Salvatore F, Rotoli B.
    Haematologica; 2000 May; 85(5):496-501. PubMed ID: 10800166
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients.
    Akiyama T, Okino T, Konishi H, Wani Y, Notohara K, Tsukayama C, Tsunoda T, Tasaka T, Masaki Y, Sugihara T, Sadahira Y.
    Pathol Int; 2008 Oct; 58(10):626-34. PubMed ID: 18801082
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ, Dolce K, Koopman T, Shuman W, Chun R, Garrett L, Barber L, Avery A.
    Vet Immunol Immunopathol; 2005 Jul 15; 106(3-4):179-96. PubMed ID: 15963817
    [Abstract] [Full Text] [Related]

  • 9. Hepatosplenic gammadelta T-cell lymphoma following seven malaria infections.
    Hassan R, Franco SA, Stefanoff CG, Romano SO, Diamond HR, Franco LG, Seuánez HN, Zalcberg IR.
    Pathol Int; 2006 Nov 15; 56(11):668-73. PubMed ID: 17040289
    [Abstract] [Full Text] [Related]

  • 10. Cytotoxic hepatosplenic gammadelta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biologic and clinical features.
    Weidmann E, Hinz T, Klein S, Schui DK, Harder S, Kriener S, Kabelitz D, Hoelzer D, Mitrou PS.
    Haematologica; 2000 Oct 15; 85(10):1024-31. PubMed ID: 11025592
    [Abstract] [Full Text] [Related]

  • 11. T-cell receptor gammadelta-large granular lymphocytic leukemia associated with an aberrant phenotype and TCR-Vbeta20 clonality.
    Vartholomatos G, Alymara V, Dova L, Kolaitis N, Bourantas KL.
    Haematologica; 2004 May 15; 89(5):ECR16. PubMed ID: 15136245
    [Abstract] [Full Text] [Related]

  • 12. Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients. Report of two cases and review of literature.
    Khan WA, Yu L, Eisenbrey AB, Crisan D, al Saadi A, Davis BH, Hankin RC, Mattson JC.
    Am J Clin Pathol; 2001 Jul 15; 116(1):41-50. PubMed ID: 11447750
    [Abstract] [Full Text] [Related]

  • 13. The correlation between the percent of CD3- CD56+ cells and NK precursor function.
    Gharehbaghian A, Donaldson C, Newman J, Bannister G, Bradley BA.
    Iran J Allergy Asthma Immunol; 2006 Dec 15; 5(4):167-75. PubMed ID: 17237569
    [Abstract] [Full Text] [Related]

  • 14. The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.
    Dalmazzo LF, Jácomo RH, Marinato AF, Figueiredo-Pontes LL, Cunha RL, Garcia AB, Rego EM, Falcão RP.
    Br J Haematol; 2009 Jan 15; 144(2):223-9. PubMed ID: 19016721
    [Abstract] [Full Text] [Related]

  • 15. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin: a case report.
    Ichinohasama R, Endoh K, Ishizawa K, Okuda M, Kameoka J, Meguro K, Myers J, Kadin ME, Mori S, Sawai T.
    Cancer; 1996 Jun 15; 77(12):2592-603. PubMed ID: 8640711
    [Abstract] [Full Text] [Related]

  • 16. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status.
    Ko YH, Cho EY, Kim JE, Lee SS, Huh JR, Chang HK, Yang WI, Kim CW, Kim SW, Ree HJ.
    Histopathology; 2004 May 15; 44(5):480-9. PubMed ID: 15139996
    [Abstract] [Full Text] [Related]

  • 17. Ex vivo expansion of natural killer cells for clinical applications.
    Klingemann HG, Martinson J.
    Cytotherapy; 2004 May 15; 6(1):15-22. PubMed ID: 14985163
    [Abstract] [Full Text] [Related]

  • 18. [Reversed C.P.C.: Aggressive NK-cell leukemia/lymphoma].
    Koyama T.
    Rinsho Byori; 2001 Mar 15; Suppl 115():140-3. PubMed ID: 11391932
    [Abstract] [Full Text] [Related]

  • 19. High frequency of EBV association and 30-bp deletion in the LMP-1 gene in CD56 lymphomas of the upper aerodigestive tract.
    Tai YC, Kim LH, Peh SC.
    Pathol Int; 2004 Mar 15; 54(3):158-66. PubMed ID: 14989738
    [Abstract] [Full Text] [Related]

  • 20. De novo CD3 negative hepatosplenic T-cell lymphoma: diagnostic challenges and pitfalls.
    Kapur LH, Khaled Y, Solh M, Ward D, Chang CC.
    Arch Pathol Lab Med; 2014 Jul 15; 138(7):969-73. PubMed ID: 24978925
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.